Promethazine Dosing for Nausea in a 60 kg Adult Male
For nausea in a 60 kg adult male, administer promethazine 12.5–25 mg intravenously (infused slowly at ≤25 mg/min) or intramuscularly, with repeat doses every 4–6 hours as needed.
Recommended Dosing
Based on FDA labeling and clinical guidelines, the standard approach is:
- Initial dose: 12.5–25 mg IV (slow infusion) or IM 1
- Repeat dosing: May repeat every 4–6 hours as needed 1
- Maximum consideration: Total doses up to 25–50 mg have been used in clinical practice 2
The FDA label specifically states that for nausea and vomiting, 25 mg is the average effective dose, with 12.5–25 mg doses repeated at 4–6 hour intervals as necessary 1. The clinical effects are evident within 5 minutes of IV administration, with a duration of action of 4–6 hours 3.
Critical Administration Guidelines
Intravenous administration requires extreme caution:
- Infuse slowly at a rate not exceeding 25 mg/min to minimize hypotension risk 3
- Preferred route is intramuscular due to serious tissue injury risks with IV administration 2, 4
- Adverse reactions including burning, pain, thrombophlebitis, tissue necrosis, and gangrene can occur with inadvertent perivascular extravasation or intra-arterial injection 2
Dosing Interval Rationale
The 4–6 hour dosing interval is based on:
- Duration of action: 4–6 hours 3
- Plasma half-life: 9–16 hours 3
- Clinical practice patterns documented in guidelines 5, 6
Lower Dose Considerations
Recent evidence suggests lower doses may be equally effective with less sedation. A randomized controlled trial found that promethazine 6.25 mg IV provided equivalent nausea relief to 12.5 mg but with significantly less sedation 7, 8. For a 60 kg patient, starting with 12.5 mg is reasonable, with the option to use 6.25 mg if sedation is a concern.
Important Safety Warnings
- Respiratory depression risk: Promethazine can cause respiratory depression, particularly when combined with opioids or other CNS depressants 3
- Extrapyramidal effects: Range from restlessness to oculogyric crises 3
- Hypotension: Common adverse effect, especially with rapid IV administration 3
- Neuroleptic malignant syndrome: Rare but serious complication 3
Alternative Antiemetic Consideration
Given the safety concerns with injectable promethazine, consider alternative antiemetics such as ondansetron (8–16 mg IV) or metoclopramide (10 mg IV) as first-line options, reserving promethazine for breakthrough nausea or when other agents have failed 5, 6, 9, 4.